{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T15:18:06Z","timestamp":1771082286240,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T00:00:00Z","timestamp":1527897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T00:00:00Z","timestamp":1527897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s11096-018-0665-1","type":"journal-article","created":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T03:46:05Z","timestamp":1527911165000},"page":"852-861","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Using a cancer registry to capture signals of adverse events following immune and targeted therapy for melanoma"],"prefix":"10.1007","volume":"40","author":[{"given":"Jo\u00e3o P.","family":"Aguiar","sequence":"first","affiliation":[]},{"given":"F\u00e1bio","family":"Cardoso Borges","sequence":"additional","affiliation":[]},{"given":"Rodrigo","family":"Murteira","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Ramos","sequence":"additional","affiliation":[]},{"given":"Emanuel","family":"Gouveia","sequence":"additional","affiliation":[]},{"given":"Maria Jos\u00e9","family":"Passos","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Miranda","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0562-2514","authenticated-orcid":false,"given":"Filipa Alves","family":"da Costa","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,6,2]]},"reference":[{"issue":"13","key":"665_CR1","first-page":"987","volume":"55","author":"R Lucas","year":"2006","unstructured":"Lucas R, McMichael T, Smith W, Armstrong B. Solar ultraviolet radiation: global burden of disease from solar ultraviolet radiation. Environ Burd Dis Ser. 2006;55(13):987\u201399.","journal-title":"Environ Burd Dis Ser"},{"key":"665_CR2","unstructured":"World Health Organization (WHO). Skin cancers. http:\/\/www.who.int\/uv\/faq\/skincancer\/en\/index1.html. Accessed 11 Mar 2017."},{"key":"665_CR3","unstructured":"European Cancer Observatory. EUCAN Factsheets: Malignant Melanoma of Skin [Internet]. Cancer Factsheets. 2012 [cited 2017 Dec 17]. http:\/\/eco.iarc.fr\/EUCAN\/Cancer.aspx?Cancer=20."},{"issue":"9","key":"665_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1470-2045(14)70301-8","volume":"15","author":"A Ribas","year":"2014","unstructured":"Ribas A, Gonzalez R, Pavlick A, Hamid O, Gajewski TF, Daud A, et al. Combination of vemurafenib and cobimetinib in patients with advanced BRAFV600-mutated melanoma: a phase 1b study. Lancet Oncol. 2014;15(9):954\u201365.","journal-title":"Lancet Oncol"},{"issue":"9839","key":"665_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","volume":"380","author":"A Hauschild","year":"2012","unstructured":"Hauschild A, Grob JJ, Demidov LV, Jouary T, Gutzmer R, Millward M, et al. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial. Lancet. 2012;380(9839):358\u201365.","journal-title":"Lancet"},{"key":"665_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejca.2015.09.013","volume":"53","author":"S Ugurel","year":"2016","unstructured":"Ugurel S, R\u00f6hmel J, Ascierto PA, Flaherty KT, Grob JJ, Hauschild A, et al. Survival of patients with advanced metastatic melanoma: the impact of novel therapies. Eur J Cancer. 2016;53:125\u201334.","journal-title":"Eur J Cancer"},{"key":"665_CR7","unstructured":"World Health Organization. International Classification of Diseases for Oncology (ICD-O)\u20143rd edition 1st revision. WHO Library Cataloguing-in-Publication Data. 2013."},{"issue":"6","key":"665_CR8","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471\u20134.","journal-title":"Ann Surg Oncol"},{"key":"665_CR9","unstructured":"Guideline on good pharmacovigilance practices (GVP)\u2014Annex I (Rev 2) EMA\/876333\/2011 Rev 2 (superseded version) available at http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2014\/04\/WC500165593.pdf. Assessed 5th May 2018."}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-018-0665-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-018-0665-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-018-0665-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:44:13Z","timestamp":1613609053000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-018-0665-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,2]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["665"],"URL":"https:\/\/doi.org\/10.1007\/s11096-018-0665-1","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,2]]},"assertion":[{"value":"9 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}